marketing agreement
Maverick Health to Offer Visby Medical Rapid Coronavirus Test
Visby's single-use, fully integrated assay is designed to detect SARS-CoV-2 nucleic acid in samples collected either by a healthcare provider or self-collected.
Euroimmun to Sell Oncgnostics Cervical Cancer Test in Certain Parts of Europe
Oncgnostics also expects the test to be approved by regulators in Canada and to be sold there by the end of the year.
Fulgent Genetics, BioIQ Partner on NGS-Based SARS-CoV-2 Variant Detection
BioIQ will offer Fulgent's next-generation sequencing-based coronavirus assay on its diagnostic testing platform.
Genetron Health to Partner With Sino Biopharm Subsidiary to Comarket Liver Cancer Test in China
Chia Tai Tianqing Pharmaceutical Group has agreed to copromote Genetron's HCCscreen test in hospitals where the pharma firm has an established presence.
Adaptive Biotechnologies, Q2 Solutions Sign Marketing Agreement for ImmunoSeq Assay
Q2 Solutions will run Adaptive's NGS-based immune cell receptor profiling assay for its pharma and biotech clients, potentially in COVID-19 vaccine trials.